Press release content from Business Wire. The AP news staff was not involved in its creation.
Genetron Health Presented Its Proprietary Early Screening Technology Mutation Capsule at Science/AAAS Webinar
April 1, 2021 GMT
Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH) sponsored a
Science /AAAS Webinar, “Early cancer screening today and tomorrow: Exploring liquid biopsy profiling for diagnosis and treatment”, which launched today.
During the panel discussion, Genetron Health’s Chief Technology Officer, Dr. Yuchen Jiao, gave a speech entitled “Profiling cfDNA-based Biomarkers for the Early Detection of Cancer”. In his presentation, Dr. Jiao highlighted the importance of early detection as the most effective method to prevent deaths from cancer.
Earnings Scheduled For March 25, 2021 benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.